STAT+: Sanofi licenses CRISPR enzyme in bid to develop safer, simpler sickle cell cure
Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid…
Category: sickle cell disease
STAT+: Even with gene therapy on the horizon, drugmakers join hunt for new sickle cell drugs
Next year, two curative gene therapies could be approved for sickle cell disease. Yet drugmakers…
STAT Plus: New data in sickle cell show biotech companies tackling disease in novel ways
Sickle cell disease features prominently at this year’s virtual meeting of the European Hematology Association,…